Company / EPS (Diluted)
Arcutis Biotherapeutics, Inc. EPS (Diluted) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$3.78
FY2025
5-year range
-$5.66 / -$3.78
FY2021-FY2025
Trend
+33.2%
vs FY2024
Sector context
#159 of 204
Health Care
What the data says
Arcutis Biotherapeutics, Inc.'s eps (diluted) of $-3.78 is lower than 78% of companies in the Health Care sector (FY2025). EPS (Diluted) has fluctuated over the past 7 years, ranging from $-22.78 in FY2019 to $-3.78 in FY2025.
Based on SEC 10-K filings.
-3.78 in FY2025.
Remained stable around $-3.78 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 204This company -$3.78 Sector average -$0.98
▼
-285.9% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 33.2% year-over-year.
- Ranks #159 out of 204 companies in the Health Care sector.
- Lowest eps (diluted) in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.78 | +33.2% |
| FY2024 | -$5.66 | -49.7% |
| FY2023 | -$3.78 | +33.2% |
| FY2022 | -$5.66 | -35.4% |
| FY2021 | -$4.18 | -10.0% |
| FY2020 | -$3.80 | +83.3% |
| FY2019 | -$22.78 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026